XML 51 R31.htm IDEA: XBRL DOCUMENT v3.6.0.2
Loan Participations Sold, Net (Tables)
12 Months Ended
Dec. 31, 2016
Debt Disclosure [Abstract]  
Summary of Statistics for Loan Participations Sold

The following table details statistics for our loan participations sold ($ in thousands):

 

     December 31, 2016  

Loan Participations Sold

   Count    Principal
Balance
     Book
Value
     Wtd. Avg.
Yield/Cost(1)
    Guarantee(2)      Wtd. Avg.
Term
 
                

Total loan

   1    $         419,560       $         416,233         L+4.48     n/a         Dec. 2019   

Senior participation(3)(4)

   1      349,633         348,077         L+2.72   $         29,616         Dec. 2019   

 

     December 31, 2015  

Loan Participations Sold

   Count    Principal
Balance
     Book
Value
     Wtd. Avg.
Yield/Cost(1)
    Guarantee(2)      Wtd. Avg.
Term
 
                

Total loan

   3    $         608,554       $         604,321         L+4.15     n/a         Nov. 2018   

Senior participation(3)(4)

   3      498,992         497,032         L+2.49   $         35,558         Nov. 2018   

 

(1)

Our floating rate loans and related liabilities were indexed to the various benchmark rates relevant in each arrangement in terms of currency and payment frequency. Therefore the net exposure to each benchmark rate is in direct proportion to our net assets indexed to that rate. In addition to cash coupon, yield/cost includes the amortization of deferred fees / financing costs.

(2)

Other than one instance where we entered into a related guarantee agreement for £24.0 million ($29.6 million and $35.6 million as of December 31, 2016 and 2015, respectively), our loan participations sold are non-recourse to us.

(3)

During the years ended December 31, 2016 and 2015, we recorded $13.7 million and $18.3 million, respectively, of interest expense related to our loan participations sold, of which $13.1 million and $16.9 million was paid in cash.

(4)

The difference between principal balance and book value of loan participations sold is due to deferred financing costs of $1.6 million and $2.0 million as of December 31, 2016 and 2015, respectively.